Le Bourgeois, A <br/><br/>
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Sep 2017 
 - 2191-2198 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdx274  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Busulfan--administration & dosage<br/>Female<br/>Graft vs Host Disease<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Survival Analysis<br/>Transplantation Conditioning<br/>Vidarabine--administration & dosage<br/>Young Adult